XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Impact of ASU No. 2022-02 Adoption
Common stock
Additional paid-in capital
Unearned compensation
Retained earnings (deficit)
Retained earnings (deficit)
Impact of ASU No. 2022-02 Adoption
Accumulated other comprehensive (loss)
Treasury stock
Balance at beginning of period (in shares) at Dec. 31, 2021     48,667,000            
Balance at Beginning of Period at Dec. 31, 2021 $ 1,182,435 $ 0 $ 528 $ 1,423,445 $ (9,056) $ (139,383)   $ (3,243) $ (89,856)
Comprehensive income (loss)                  
Net income 43,311         43,311      
Other comprehensive (loss) (119,756)             (119,756)  
Total comprehensive (loss)/income (76,445)         43,311   (119,756)  
Cash dividends declared on common shares (10,921)         (10,921)      
Treasury shares repurchased (in shares)     (3,119,000)            
Treasury shares repurchased (84,295)               (84,295)
Forfeited shares (in shares)     (51,000)            
Forfeited shares 0     79 1,358       (1,437)
Exercise of stock options (in shares)     1,000            
Exercise of stock options 25         (4)     29
Restricted stock grants (in shares)     314,000            
Restricted stock grants 0     552 (9,052)       8,500
Stock-based compensation 3,926       3,926        
Other, net (in shares)     (24,000)            
Other, net (675)     5         (680)
Balance at end of period (in shares) at Jun. 30, 2022     45,788,000            
Balance at End of Period at Jun. 30, 2022 1,014,050   $ 528 1,424,081 (12,824) (106,997)   (122,999) (167,739)
Balance at beginning of period (in shares) at Mar. 31, 2022     47,792,000            
Balance at Beginning of Period at Mar. 31, 2022 1,093,861   $ 528 1,423,679 (10,284) (125,343)   (78,237) (116,482)
Comprehensive income (loss)                  
Net income 23,115         23,115      
Other comprehensive (loss) (44,762)             (44,762)  
Total comprehensive (loss)/income (21,647)         23,115   (44,762)  
Cash dividends declared on common shares (4,769)         (4,769)      
Treasury shares repurchased (in shares)     (2,147,000)            
Treasury shares repurchased (55,040)               (55,040)
Forfeited shares (in shares)     (15,000)            
Forfeited shares 0     9 375       (384)
Exercise of stock options 0                
Restricted stock grants (in shares)     175,000            
Restricted stock grants 0     391 (5,035)       4,644
Stock-based compensation 2,120       2,120        
Other, net (in shares)     (17,000)            
Other, net (475)     2         (477)
Balance at end of period (in shares) at Jun. 30, 2022     45,788,000            
Balance at End of Period at Jun. 30, 2022 $ 1,014,050   $ 528 1,424,081 (12,824) (106,997)   (122,999) (167,739)
Balance at beginning of period (in shares) at Dec. 31, 2022 44,361,222   44,361,000            
Balance at Beginning of Period at Dec. 31, 2022 $ 954,062 401 $ 528 1,424,183 (8,598) (71,428) $ 401 (181,052) (209,571)
Comprehensive income (loss)                  
Net income 51,498         51,498      
Other comprehensive (loss) (5,188)             (5,188)  
Total comprehensive (loss)/income 46,310         51,498   (5,188)  
Cash dividends declared on common shares (15,961)         (15,961)      
Treasury shares repurchased (in shares)     (628,000)            
Treasury shares repurchased (13,568)               (13,568)
Forfeited shares (in shares)     (49,000)            
Forfeited shares 0     37 1,261       (1,298)
Exercise of stock options 0                
Restricted stock grants (in shares)     392,000            
Restricted stock grants 0     (209) (10,587)       10,796
Stock-based compensation 3,454       3,454        
Other, net (in shares)     (43,000)            
Other, net $ (1,317)     (155)         (1,162)
Balance at end of period (in shares) at Jun. 30, 2023 44,033,094   44,033,000            
Balance at End of Period at Jun. 30, 2023 $ 973,381   $ 528 1,423,856 (14,470) (35,490)   (186,240) (214,803)
Balance at beginning of period (in shares) at Mar. 31, 2023     44,411,000            
Balance at Beginning of Period at Mar. 31, 2023 995,480 $ 0 $ 528 1,424,563 (10,920) (51,398) $ 0 (159,066) (208,227)
Comprehensive income (loss)                  
Net income 23,861         23,861      
Other comprehensive (loss) (27,174)             (27,174)  
Total comprehensive (loss)/income (3,313)         23,861   (27,174)  
Cash dividends declared on common shares (7,953)         (7,953)      
Treasury shares repurchased (in shares)     (581,000)            
Treasury shares repurchased (12,378)               (12,378)
Forfeited shares (in shares)     (18,000)            
Forfeited shares 0     (50) 428       (378)
Exercise of stock options 0                
Restricted stock grants (in shares)     249,000            
Restricted stock grants 0     (654) (6,236)       6,890
Stock-based compensation 2,258       2,258        
Other, net (in shares)     (28,000)            
Other, net $ (713)     (3)         (710)
Balance at end of period (in shares) at Jun. 30, 2023 44,033,094   44,033,000            
Balance at End of Period at Jun. 30, 2023 $ 973,381   $ 528 $ 1,423,856 $ (14,470) $ (35,490)   $ (186,240) $ (214,803)